Arduini takes over the board chair spot from former Johnson & Johnson MedTech head Ashley McEvoy. McEvoy resigned from her position at J&J in October and subsequently stepped down as AdvaMed chair less than a year into a two-year term.
“The timing of Peter Arduini’s election as our new chair couldn’t be better,” AdvaMed President and CEO Scott Whitaker said in a news release. “His leadership of GE HealthCare, a global leader in medical imaging, pharmaceutical diagnostics and digital solutions, will provide strategic insight and direction to AdvaMed as we work to ensure an aligned and inclusive focus across companies in every sector of medtech.”
As the medtech advocacy organization named Arduini to lead its board, it also established a new medical imaging technology division. The division’s focus centers around advocating on behalf of imaging technology, radiopharmaceuticals, contrast media and focused ultrasound devices.
Leading companies like Arduini’s GE HealthCare formally established AdvaMed as their new home for advocacy.
“We are in a new era in which providers and patients rely on medical imaging and digital solutions for critical insights across the entire care pathway from screening, diagnosis, monitoring, and therapy delivery, as well as research and discovery,” Arduini said. “As chair, I look forward to working alongside Scott and my colleagues from across the industry to establish AdvaMed’s new imaging division and ensure it is aligned and integrated to our overall goals of the medtech industry.”
More about the new medical imaging division at AdvaMed
Other member companies mentioned by AdvaMed include Bayer, Fujifilm Sonosite, Hologic, Philips and Siemens Healthineers. These companies previously sat within the Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA).
The launch of the new division follows last month’s establishment of a digital health division at AdvaMed. Like the organization’s other divisions, the medical imaging technology sector will be led by a board of directors comprised of executives from its imaging company members.
AdvaMed chose former MITA Executive Director, Patrick Hope, to lead as executive director of the new division. Hope and Peter Weems, who led MITA’s government affairs and policy strategy, will round out staffing needs going forward.
“Our new home at AdvaMed makes perfect sense,” Hope said. “For the first time, we will be surrounded by a team, infrastructure, and resources focused entirely on the patients our companies serve. We will be surrounded by and working directly with experts in medtech policy at the state, national, and global levels. I am 100 percent confident that our companies will see more value in our work together under the AdvaMed umbrella than ever before.”
Whitaker called the new division a “big step forward” for medical imaging, AdvaMed and the entire medtech industry.
“Never before have medical technologies been so connected and interdependent as they are today—and it’s really only the beginning. From traditional medical devices to digital health tech to AI and medical imaging, the opportunity to unify the industry and advance policy solutions for the healthcare system has never been better,” Whitaker said. “No trade organization is better prepared than AdvaMed to represent the entire medtech industry and take on these advocacy challenges so that our members can continue focusing on what they do best— meeting the needs of the patients they serve.
